ATP1A3 and dystonia 12: The results presented here strengthen the ongoing debate of the complexity of the ATP1A3-related diseases: Why some mutations are specific to RDP, AHC or CAPOS, and why the same mutations may produce intermediate symptoms could give rise to so very different disease courses.